WuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUI™ in 2,000L GMP Manufacturing

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

WuXi-Biologics-WuXiUI

More Like This

WuXi Biologics Successfully Completes First 16,000L Manufacturing Run in Ireland

WuXi Biologics to Increase Manufacturing Capacity in Massachusetts

WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics

WuXi Biologics Reports Solid 2024 Interim Results

WuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes Line

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital